Get the Stockscreener App
0.1085
2.69%
-0.003
Pre-market:
.14
0.0315
+29.03%
Liminatus Pharma Inc stock is traded at $0.1085, with a volume of 1.14M.
It is down -2.69% in the last 24 hours and down -5.16% over the past month.
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
See More
Previous Close:
$0.1115
Open:
$0.1122
24h Volume:
1.14M
Relative Volume:
0.04
Market Cap:
$7.29M
Revenue:
-
Net Income/Loss:
$-11.00M
P/E Ratio:
-0.2743
EPS:
-0.3956
Net Cash Flow:
$-11.99M
1W Performance:
+3.33%
1M Performance:
-5.16%
6M Performance:
-77.63%
1Y Performance:
-97.51%
1-Day Range:
$0.1067
$0.1143
1-Week Range:
$0.096
$0.1248
52-Week Range:
$0.095
$4.85
Liminatus Pharma Inc Stock (LIMN) Company Profile
Name
Liminatus Pharma Inc
Sector
Industry
Phone
213-273-5453
Address
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1085 | 7.49M | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
525.73 | 134.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
797.99 | 82.06B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
876.00 | 54.10B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.26 | 44.06B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.05 | 40.64B | 5.76B | 514.49M | 1.10B | 4.4813 |
Liminatus Pharma Inc Stock (LIMN) Latest News
Liminatus Pharma Shareholders Approve Reverse Stock Split Plan - The Globe and Mail
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMN - tradingview.com
Liminatus Pharma (NASDAQ: LIMN) cites $2.5M equity in Nasdaq compliance review - Stock Titan
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Revenue Breakdown – BOATS:LIMN - TradingView
Liminatus Pharma Faces Nasdaq Delisting Risk, Plans Reverse Split - TipRanks
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) Stock Price, News & Analysis - Kalkine
Samda Biolab discloses 5.1% Liminatus Pharma (LIMN) ownership position - Stock Titan
$Liminatus Pharma (LIMN.US)$ - Moomoo
Frontier tech research, news & data - MLQ.ai
Liminatus Pharma Warrants (LIMNW) Edge Higher: A Closer Look at the $0.06 LevelPrice Action Signals - dars.gov.et
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Price to earnings forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Liminatus Pharma (LIMN) - Moomoo
Curious about the most active stocks on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session - Sahm
Form 13D/A Liminatus Pharma For: 14 July By Investing.com - Investing.com Nigeria
Form 4 Liminatus Pharma Inc For: 14 July By Investing.com - Investing.com Nigeria
Liminatus Pharma (LIMN) investors Valetudo and Chris Kim report 9.6M-share stake - Stock Titan
Liminatus Pharma Warrants (LIMNW) Hold Steady at $0.05 in Stagnant TradingStrong Buy Stocks - dars.gov.et
Form DEF 14A Liminatus Pharma Inc For: 13 July By Investing.com - Investing.com Nigeria
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Price to sales forward of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Price to sales forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Liminatus Pharma(LIMN) Stock Options Chain | Quotes & News - Moomoo
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Number of employees of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Price to earnings forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Form 4 Liminatus Pharma Inc For: 6 July By Investing.com - Investing.com Nigeria
4.37M Liminatus (NASDAQ: LIMN) shares moved in entity transfer - Stock Titan
Ewon Comfortech discloses 5.5M Liminatus Pharma (LIMN) shares - Stock Titan
Ewon Comfortech discloses 5.5M shares in Liminatus Pharma (NASDAQ: LIMN) - Stock Titan
Liminatus Pharma Closes InnocsAI Merger and Share Issuance - TipRanks
Liminatus Pharma (LIMN) completes InnocsAI acquisition with large convertible preferred stake - Stock Titan
Enterprise value to revenue forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - tradingview.com
LIMNLiminatus Pharma Inc Options - Finviz
LIMN Should I Buy - Intellectia AI
Thursday's session: most active stocks - ChartMill
Get insights into the top gainers and losers of Thursday's pre-market session. - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga
Liminatus Pharma (LIMN) stock is trending overnight — here’s why it spiked over 30% in after-hours session (updated) - MSN
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline - The Manila Times
Liminatus amends InnocsAI merger, closing set for July 2 By Investing.com - Investing.com India
Liminatus amends InnocsAI merger, closing set for July 2 - Investing.com
Trending Stocks Today | LogProStyle Surges 72.41% Post-Market - Moomoo
Liminatus Pharma Inc Stock (LIMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.12%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):